Key Financial Data Of Group

Astellas Pharma Inc. - Filing #7540970

Concept As at
2023-09-30
2023-07-01 to
2023-09-30
2023-04-01 to
2023-09-30
As at
2023-03-31
2022-04-01 to
2023-03-31
2022-07-01 to
2022-09-30
As at
2022-09-30
2022-04-01 to
2022-09-30
Key financial data of group
Business results of group
Revenue
392,147,000,000 JPY
767,138,000,000 JPY
1,518,619,000,000 JPY
380,394,000,000 JPY
762,185,000,000 JPY
Profit (loss) before tax
52,178,000,000 JPY
132,361,000,000 JPY
120,480,000,000 JPY
Profit (loss), attributable to owners of parent
-1,459,000,000 JPY
31,670,000,000 JPY
98,714,000,000 JPY
71,623,000,000 JPY
96,434,000,000 JPY
Comprehensive income, attributable to owners of parent
188,288,000,000 JPY
205,277,000,000 JPY
243,707,000,000 JPY
Equity attributable to owners of parent
1,639,345,000,000 JPY
1,507,954,000,000 JPY
1,649,518,000,000 JPY
Total assets
3,543,021,000,000 JPY
2,456,518,000,000 JPY
2,583,661,000,000 JPY
Basic earnings (loss) per share
-0.81
17.66
54.24
39.30
52.87
Diluted earnings (loss) per share
17.60
54.09
52.85
Ratio of owners' equity to gross assets
0.463 xbrli:pure
0.614 xbrli:pure
0.638 xbrli:pure
Cash flows from (used in) operating activities
49,082,000,000 JPY
327,767,000,000 JPY
139,857,000,000 JPY
Cash flows from (used in) investing activities
-783,332,000,000 JPY
-84,500,000,000 JPY
-34,660,000,000 JPY
Cash flows from (used in) financing activities
670,156,000,000 JPY
-195,623,000,000 JPY
-81,431,000,000 JPY
Cash and cash equivalents
333,993,000,000 JPY
376,840,000,000 JPY
361,073,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.